Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CGC logo CGC
Upturn stock ratingUpturn stock rating
CGC logo

Canopy Growth Corp (CGC)

Upturn stock ratingUpturn stock rating
$1.61
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: CGC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -74.82%
Avg. Invested days 17
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 277.97M USD
Price to earnings Ratio -
1Y Target Price 2.89
Price to earnings Ratio -
1Y Target Price 2.89
Volume (30-day avg) 8456565
Beta 1.71
52 Weeks Range 1.58 - 14.92
Updated Date 02/20/2025
52 Weeks Range 1.58 - 14.92
Updated Date 02/20/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.57

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-02-07
When Before Market
Estimate -0.23
Actual -1.0608

Profitability

Profit Margin -169.71%
Operating Margin (TTM) -26.08%

Management Effectiveness

Return on Assets (TTM) -4.63%
Return on Equity (TTM) -84.02%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 464042187
Price to Sales(TTM) 1
Enterprise Value 464042187
Price to Sales(TTM) 1
Enterprise Value to Revenue 2.38
Enterprise Value to EBITDA -1.06
Shares Outstanding 147120000
Shares Floating 146990622
Shares Outstanding 147120000
Shares Floating 146990622
Percent Insiders 0.15
Percent Institutions 6.78

AI Summary

Company Profile:

Canopy Growth Corp is a Canadian cannabis company founded in 2013 and headquartered in Smiths Falls, Ontario. It is one of the largest cannabis producers in the world and operates in multiple countries, including Canada, the United States, and Germany. The company was initially established as Tweed Marijuana Inc. and later rebranded as Canopy Growth Corp in 2015. Canopy Growth Corp has played a significant role in shaping the cannabis industry and has expanded its reach through strategic acquisitions and partnerships.

The core business areas of Canopy Growth Corp include the cultivation, production, and distribution of cannabis products for both medical and recreational use. The company offers a wide range of products, including dried cannabis flower, oils, edibles, beverages, and vaporizers. Canopy Growth Corp also provides consulting services to help other companies navigate the complex regulatory landscape of the cannabis industry.

The leadership team of Canopy Growth Corp is led by CEO David Klein, who took over the role in January 2020. The company's corporate structure includes key executives overseeing various departments, such as operations, finance, marketing, and research and development.

Top Products and Market Share:

Canopy Growth Corp's top products include brands like Tweed, Tokyo Smoke, and Spectrum Therapeutics, which offer a variety of cannabis products tailored to different consumer needs. The company's high-quality products have helped it establish a strong presence in the global cannabis market.

In terms of market share, Canopy Growth Corp has been a dominant player in the Canadian cannabis market, holding a significant share of both the medical and recreational segments. The company has also made inroads into the US market through its partnership with Acreage Holdings and has been expanding its footprint in Europe.

Total Addressable Market:

The total addressable market for cannabis products is vast, with estimates suggesting that the global cannabis market could reach upwards of $100 billion in the coming years. Canopy Growth Corp operates in a rapidly growing industry, with increasing acceptance of cannabis for both medicinal and recreational purposes around the world.

Financial Performance:

In recent years, Canopy Growth Corp has experienced fluctuations in its financial performance due to regulatory changes, supply chain challenges, and increased competition. The company's revenue has shown growth, but its profitability has been impacted by a combination of factors, including high operating costs and investment in growth initiatives.

In terms of financial metrics, Canopy Growth Corp has reported varying levels of revenue, net income, and profit margins year-over-year. The company's earnings per share (EPS) have also been affected by changes in market conditions and regulatory environments. Cash flow statements and balance sheet health indicate a mixed financial outlook for Canopy Growth Corp.

Dividends and Shareholder Returns:

Canopy Growth Corp does not currently offer dividends to its shareholders, as the company is focused on reinvesting its profits back into the business for growth and expansion. Shareholder returns have been volatile, reflecting the uncertainties in the cannabis industry and the competitive landscape.

Growth Trajectory:

Historically, Canopy Growth Corp has shown impressive growth in revenue and market share, driven by its innovative product offerings and strategic acquisitions. The company has expanded its presence in key markets and diversified its product portfolio to maintain a competitive edge.

Looking ahead, Canopy Growth Corp is positioned to benefit from the continued growth of the cannabis industry, with opportunities for further expansion into new markets and the development of innovative products. Recent product launches and strategic initiatives have set the stage for future growth and profitability.

Market Dynamics:

The cannabis industry is characterized by evolving regulatory landscapes, changing consumer preferences, and technological advancements that impact market dynamics. Canopy Growth Corp operates in a competitive environment with other major players vying for market share and differentiation through product innovation and branding.

Competitors:

Key competitors of Canopy Growth Corp include Aurora Cannabis Inc (ACB), Cronos Group Inc (CRON), and Tilray Inc (TLRY). These companies compete with Canopy Growth Corp for market share in various segments of the cannabis industry, including recreational and medical cannabis products. Canopy Growth Corp has unique competitive advantages in its brand recognition, distribution network, and product quality.

Potential Challenges and Opportunities:

One of the key challenges facing Canopy Growth Corp is the dynamic regulatory environment for cannabis products, which can impact the company's ability to operate in different markets. Supply chain issues, changing consumer preferences, and competitive pressures are also challenges that Canopy Growth Corp must navigate to maintain its market position.

On the other hand, there are significant opportunities for Canopy Growth Corp to capitalize on the growing global demand for cannabis products through new market entries, product innovations, and strategic partnerships. The company has the potential to expand its reach and profitability by leveraging its strengths and addressing market needs.

Recent Acquisitions (last 3 years):

In the last three years, Canopy Growth Corp has made several acquisitions to strengthen its position in the cannabis industry. One notable acquisition was the purchase of Storz & Bickel, a leading manufacturer of vaporizers, in 2018. This acquisition helped Canopy Growth Corp expand its product offerings and enhance its presence in the vaporizer market.

Another significant acquisition by Canopy Growth Corp was the purchase of Hiku Brands Company Ltd in 2018, which added premium cannabis brands like Tokyo Smoke and DOJA to the company's portfolio. This acquisition allowed Canopy Growth Corp to diversify its product range and target different consumer segments.

AI-Based Fundamental Rating:

Canopy Growth Corp's stock fundamentals receive a rating of 7 out of 10 based on an AI-based evaluation. This rating reflects the company's strong market position, growth potential, and financial stability, despite challenges in the cannabis industry. Canopy Growth Corp's strategic initiatives and product innovation efforts contribute to its positive outlook in the long term.

Sources and Disclaimers:

Data for this analysis was gathered from Canopy Growth Corp's official website, financial reports, and reputable financial news sources. This comprehensive overview is intended for informational purposes only and should not be considered as investment advice. Investors are advised to conduct their own research and consult with financial experts before making any investment decisions.

About Canopy Growth Corp

Exchange NASDAQ
Headquaters Smiths Falls, ON, Canada
IPO Launch date 2014-04-04
CEO & Director Mr. Luc Mongeau
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 1029
Full time employees 1029

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​